Tender detail

Drug discount agreements for the active substance Erythropoietin, ATC B03XA01

Summary

The tender concerns the negotiation of non-exclusive discount contracts for medicines with the active substance Erythropoietin (ATC B03XA01) for the period 01 November 2026 to 31 October 2028, using an open-house model. In the Open House procedure, medicines listed as pediatric medicines according to the BfArM list are excluded.

Reference number
2e5c9586-5242-40a3-bbf3-3679ec2931b6
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-08-31
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.